Salicylate Prevents Virus-induced Type 1 Diabetes in the BBDR Rat

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Oct 23

PMID 24147110

Citations 6

Authors

Chaoxing Yang

Agata Jurczyk

Philip DiIorio

Elaine Norowski

Michael A Brehm

Christian W Grant

Dennis L Guberski

Dale L Greiner

Rita Bortell

Affiliations

Soon will be listed here.

Abstract

Epidemiologic and clinical evidence suggests that virus infection plays an important role in human type 1 diabetes pathogenesis. We used the virus-inducible BioBreeding Diabetes Resistant (BBDR) rat to investigate the ability of sodium salicylate, a non-steroidal anti-inflammatory drug (NSAID), to modulate development of type 1 diabetes. BBDR rats treated with Kilham rat virus (KRV) and polyinosinic:polycytidylic acid (pIC, a TLR3 agonist) develop diabetes at nearly 100% incidence by ~2 weeks. We found distinct temporal profiles of the proinflammatory serum cytokines, IL-1β, IL-6, IFN-γ, IL-12, and haptoglobin (an acute phase protein) in KRV+pIC treated rats. Significant elevations of IL-1β and IL-12, coupled with sustained elevations of haptoglobin, were specific to KRV+pIC and not found in rats co-treated with pIC and H1, a non-diabetogenic virus. Salicylate administered concurrently with KRV+pIC inhibited the elevations in IL-1β, IL-6, IFN-γ and haptoglobin almost completely, and reduced IL-12 levels significantly. Salicylate prevented diabetes in a dose-dependent manner, and diabetes-free animals had no evidence of insulitis. Our data support an important role for innate immunity in virus-induced type 1 diabetes pathogenesis. The ability of salicylate to prevent diabetes in this robust animal model demonstrates its potential use to prevent or attenuate human autoimmune diabetes.

Citing Articles

Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and β-cell chemokine expression associated with autoimmune diabetes susceptibility.

Henschel A, Cabrera S, Kaldunski M, Jia S, Geoffrey R, Roethle M PLoS One. 2018; 13(1):e0190351.

PMID: 29293587 PMC: 5749787. DOI: 10.1371/journal.pone.0190351.

Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model.

Roberts F, Hupple C, Norowski E, Walsh N, Przewozniak N, Aryee K PLoS One. 2017; 12(6):e0178641.

PMID: 28605395 PMC: 5468055. DOI: 10.1371/journal.pone.0178641.

Is a β cell a β cell?.

Yang C, Galivo F, Dorrell C Curr Opin Endocrinol Diabetes Obes. 2017; 24(2):92-97.

PMID: 28099206 PMC: 5638137. DOI: 10.1097/MED.0000000000000322.

End Sequence Analysis Toolkit (ESAT) expands the extractable information from single-cell RNA-seq data.

Derr A, Yang C, Zilionis R, Sergushichev A, Blodgett D, Redick S Genome Res. 2016; 26(10):1397-1410.

PMID: 27470110 PMC: 5052061. DOI: 10.1101/gr.207902.116.

Innate inflammation in type 1 diabetes.

Cabrera S, Henschel A, Hessner M Transl Res. 2015; 167(1):214-27.

PMID: 25980926 PMC: 4626442. DOI: 10.1016/j.trsl.2015.04.011.

References

Schalkwijk C, Poland D, van Dijk W, Kok A, Emeis J, Drager A . Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia. 1999; 42(3):351-7. DOI: 10.1007/s001250051162. View

Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, Lu H . A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature. 2010; 467(7314):460-4. PMC: 3657719. DOI: 10.1038/nature09386. View

Mordes J, Bortell R, Blankenhorn E, Rossini A, Greiner D . Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J. 2004; 45(3):278-91. DOI: 10.1093/ilar.45.3.278. View

Zipris D, Hillebrands J, Welsh R, Rozing J, Xie J, Mordes J . Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J Immunol. 2003; 170(7):3592-602. DOI: 10.4049/jimmunol.170.7.3592. View

Yeung W, Al-Shabeeb A, Pang C, Wilkins M, Catteau J, Howard N . Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile. Diabetes. 2012; 61(6):1500-8. PMC: 3357262. DOI: 10.2337/db11-0264. View

Devaraj S, Dasu M, Rockwood J, Winter W, Griffen S, Jialal I . Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2007; 93(2):578-83. PMC: 2243229. DOI: 10.1210/jc.2007-2185. View

Rumore M, Kim K . Potential role of salicylates in type 2 diabetes. Ann Pharmacother. 2010; 44(7-8):1207-21. DOI: 10.1345/aph.1M483. View

Ruan H, Pownall H . The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance. Curr Opin Investig Drugs. 2009; 10(4):346-52. View

Kaldunski M, Jia S, Geoffrey R, Basken J, Prosser S, Kansra S . Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat. Diabetes. 2010; 59(10):2375-85. PMC: 3279523. DOI: 10.2337/db10-0372. View

10.

Brown D, Welsh R, LIKE A . Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. J Virol. 1993; 67(10):5873-8. PMC: 238006. DOI: 10.1128/JVI.67.10.5873-5878.1993. View

11.

Redondo M, Yu L, Hawa M, Mackenzie T, Pyke D, Eisenbarth G . Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001; 44(3):354-62. DOI: 10.1007/s001250051626. View

12.

Liu S, Wang H, Jin Y, Podolsky R, Reddy M, Pedersen J . IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells. Hum Mol Genet. 2008; 18(2):358-65. PMC: 2638779. DOI: 10.1093/hmg/ddn342. View

13.

Goldfine A, Fonseca V, Jablonski K, Pyle L, Staten M, Shoelson S . The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med. 2010; 152(6):346-57. PMC: 3138470. DOI: 10.7326/0003-4819-152-6-201003160-00004. View

14.

Wolter T, Wong R, Sarkar S, Zipris D . DNA microarray analysis for the identification of innate immune pathways implicated in virus-induced autoimmune diabetes. Clin Immunol. 2009; 132(1):103-15. DOI: 10.1016/j.clim.2009.02.007. View

15.

Meyers A, Shah R, Gottlieb P, Zipris D . Altered Toll-like receptor signaling pathways in human type 1 diabetes. J Mol Med (Berl). 2010; 88(12):1221-31. DOI: 10.1007/s00109-010-0666-6. View

16.

Goldfine A, Silver R, Aldhahi W, Cai D, Tatro E, Lee J . Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci. 2009; 1(1):36-43. PMC: 2662587. DOI: 10.1111/j.1752-8062.2008.00026.x. View

17.

Yeung W, Rawlinson W, Craig M . Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ. 2011; 342:d35. PMC: 3033438. DOI: 10.1136/bmj.d35. View

18.

Kruger A, Yang C, Tam S, Hinerfeld D, Evans J, Green K . Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats. Exp Biol Med (Maywood). 2010; 235(11):1328-37. PMC: 4172443. DOI: 10.1258/ebm.2010.010150. View

19.

Castano L, Eisenbarth G . Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol. 1990; 8:647-79. DOI: 10.1146/annurev.iy.08.040190.003243. View

20.

Bortell R, Yang C . The BB rat as a model of human type 1 diabetes. Methods Mol Biol. 2012; 933:31-44. DOI: 10.1007/978-1-62703-068-7_3. View